Saxsons Group — India's trusted nuclear medicine, radiotherapy, oncosurgery, dosimetry and cyclotron supplier since 1986

All research papers

2219 approved papers, newest first · showing 541–600.Search instead →

  1. 3 Aug 2026· Thyroid : official journal of the American Thyroid Association· Diagnostic
    Prognostic Stratification of Brain Metastases from Nonanaplastic Follicular Cell-Derived Thyroid Carcinoma: Results of an International Multicenter Retrospective Study.
    Prinzi A et al.
  2. 3 Aug 2026· Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico· SBRT delivery· QA & dosimetry· Therapeutic
    Intermediate rectal dose is associated with late toxicity after prostate SBRT: a dose-volume histogram principal component analysis.
    Zurita AJW et al.
  3. 2 Aug 2026· The Prostate· Ga-68 PSMA PET· Diagnostic
    Management of De Novo miN1 Prostate Cancer in the PSMA-PET Era.
    McMaster T et al.
  4. 2 Aug 2026· Scientific reports· Diagnostic
    Detection of lung cancer using Kronecker mobile forward harmonic net.
    Prasad JR et al.
  5. 1 Aug 2026· Journal of applied clinical medical physics· SBRT delivery· QA & dosimetry· Free full text
    A geometry-based scaling model for stereotactic treatment volume definition in stereotactic centralized ablative radiation therapy.
    Siah N et al.
  6. 1 Aug 2026· Radiation protection dosimetry· Personal / occupational dosimetry· Radiation safety
    Mailed dose record review of occupational dosimetry records among Japanese medical radiation workers: the OREMS Study.
    Kitamura H et al.
  7. 1 Aug 2026· Medical physics· TLD dosimetry· QA & dosimetry· Free full text
    Lighting up FLASH and beyond: TLD response across four orders of magnitude in proton dose rate.
    Guan F et al.
  8. 1 Aug 2026· Journal of applied clinical medical physics· Gold-anchor fiducial markers· QA & dosimetry· Free full text
    Impact of MRI slice thickness and fiducial marker orientation on geometric accuracy in multi-echo GRE imaging for prostate radiotherapy planning.
    Hayashi A et al.
  9. 1 Aug 2026· Journal of applied clinical medical physics· MR-linac / MR-guided· QA & dosimetry· Free full text
    Clinical implementation and performance evaluation of a motorized MR-compatible OCTAVIUS 4D system for SBRT patient-specific QA on a 1.5 T MR-LINAC.
    Chevillard C et al.
  10. 1 Aug 2026· Medical physics· Adaptive radiotherapy· QA & dosimetry
    HyperSight CBCT dose calculation accuracy for adaptive head and neck radiotherapy: Results from a prospective clinical trial.
    Yashayaeva A et al.
  11. 1 Aug 2026· Cancer medicine· SRS / intracranial· Therapeutic
    Up to Four-Year Outcomes of Single-Fraction Stereotactic Radiosurgery for Small Brain Metastases: A Competing-Risk Analysis.
    Gruber I et al.
  12. 1 Aug 2026· Journal of applied clinical medical physics· Linac QA· QA & dosimetry
    Commissioning and clinical positioning assessment of a novel surface-guided radiation therapy (SGRT) system at a C-Arm linear accelerator.
    Looe HK et al.
  13. 1 Aug 2026· Neuro-oncology· SRS / intracranial· Therapeutic
    Intracranial progression-free survival correlates with overall survival and varies by tumor subtype in patients with breast cancer and brain metastases.
    Sammons SL et al.
  14. 1 Aug 2026· Neuro-oncology· Ac-225 alpha therapy· Therapeutic
    Radiopharmaceutical therapy provides superior survival advantage for leptomeningeal metastasis compared to external beam radiotherapy.
    Zhao L et al.
  15. 1 Aug 2026· Medical physics· Adaptive radiotherapy· QA & dosimetry
    Equivariant conditional diffusion model for head and neck CT image synthesis from CBCT.
    Altalib A et al.
  16. 1 Aug 2026· Journal of applied clinical medical physics· MR-linac / MR-guided· QA & dosimetry
    Image-based evaluation of a commercial AI synthetic CT generator for brain and prostate MR-only radiotherapy.
    Aire M et al.
  17. 1 Aug 2026· Journal of applied clinical medical physics· Adaptive radiotherapy· Therapeutic
    Initial experience of clinical implementation of an Online Simulation-free CBCT-based Adaptive Radiotherapy (OSCAR) workflow for palliative and urgent treatment indications.
    Schindhelm R et al.
  18. 1 Aug 2026· Medical physics· MR-linac / MR-guided· QA & dosimetry
    Patient-specific automated multi-class anatomical motion tracking on real-time cine MR images using deep learning techniques.
    Li K et al.
  19. 1 Aug 2026· Medical physics· QA & dosimetry
    Photon minibeam-based LATTICE radiotherapy for small and medium-sized tumors: A dosimetric planning study.
    Wu W et al.
  20. 1 Aug 2026· International journal of urology : official journal of the Japanese Urological Association· Ra-223· Therapeutic
    Real-World Outcomes of Radium-223 Therapy in Metastatic Castration-Resistant Prostate Cancer: Predictive Value of PSA Doubling Time and Enzalutamide Continuation.
    Abe K et al.
  21. 1 Aug 2026· Molecular pharmaceutics· Therapeutic
    Dual-Targeted Radionuclide Therapy with 161Tb Instigates Anticancer Immunity in "Cold" Murine Prostate Tumor.
    Sun J et al.
  22. 1 Aug 2026· Radiological physics and technology· Breast / lung positioning· QA & dosimetry
    Influence of target coverage priority levels on dose homogeneity in commercial automated field-in-field planning for breast radiotherapy.
    Miura H et al.
  23. 1 Aug 2026· Medical physics· Adaptive radiotherapy· QA & dosimetry
    Knowledge-distilled diffusion models for improving cone-beam CT image quality with meta-learning under imbalanced data.
    Hwang J et al.
  24. 1 Aug 2026· Neurosurgical review· SRS / intracranial· Therapeutic
    Clinical outcomes following cyberknife radiosurgery for cerebral arteriovenous malformations: A systematic review and meta-analysis.
    Hassan GA et al.
  25. 1 Aug 2026· Journal of applied clinical medical physics· SBRT delivery· QA & dosimetry
    Quantitative evaluation of respiratory motion-induced blurring in expiratory-phase CBCT for pancreatic SBRT.
    Nukushina A et al.
  26. 1 Aug 2026· Glia· Diagnostic
    Longitudinal Tracking of Astrocyte Reactivity During the Development of Chronic Orofacial Neuropathic Pain Using [¹⁸F]-SMBT-1 Positron-Emission Tomography.
    Crawford LS et al.
  27. 1 Aug 2026· Journal of applied clinical medical physics· Adaptive radiotherapy· QA & dosimetry
    Nominal material density may not reflect TPS-relevant density for 3D-printed surgical reconstruction implants: An educational case study.
    Ehler ED et al.
  28. 1 Aug 2026· Medical physics· Adaptive radiotherapy· QA & dosimetry
    Transformer-based rapid dose calculation for carbon ion therapy.
    Liu Y et al.
  29. 1 Aug 2026· Medical physics· MR-linac / MR-guided· QA & dosimetry
    A modality-agnostic coronary artery habitat model for cardiac sparing in radiotherapy.
    Ruff C et al.
  30. 1 Aug 2026· Journal of applied clinical medical physics· Patient-specific QA· QA & dosimetry
    Evaluation of dosimetric impact and plan robustness of MLC motion and setup errors in SRS for multiple brain metastases.
    Xu H et al.
  31. 1 Aug 2026· The British journal of radiology· SBRT delivery· Therapeutic
    Comparative efficacy of stereotactic body radiotherapy and percutaneous radiofrequency ablation for oligometastatic liver disease-radiation oncologists' perspective and practice guideline.
    Atalar B et al.
  32. 1 Aug 2026· Hematology/oncology clinics of North America· Therapeutic
    Radiation Therapy for Liver and Biliary Tract Cancers.
    Mahadevan A.
  33. 1 Aug 2026· Journal of applied clinical medical physics· SBRT delivery· QA & dosimetry
    Assessment of dose distribution in pancreatic SABR in the presence of a metallic biliary stent using Monte Carlo modeling.
    Abbas A et al.
  34. 1 Aug 2026· Journal of applied clinical medical physics· Linac QA· QA & dosimetry
    Commissioning and performance evaluations of the electron Monte Carlo algorithm in a new commercial treatment planning system.
    Wang F et al.
  35. 1 Aug 2026· Journal of applied clinical medical physics· Linac QA· QA & dosimetry
    Accelerated and standardized commissioning of a robotic RadioSurgery system using a hybrid golden beam data model.
    Pantelis E et al.
  36. 1 Aug 2026· European thyroid journal· I-131 therapy· Radiation safety· Therapeutic
    Estimation of the delay for resumption of breastfeeding after 131-iodine therapy by milk radioactivity measurement.
    Chaib S et al.
  37. 1 Aug 2026· Medical physics· Ac-225 alpha therapy· Therapeutic
    Feasibility of convection-enhanced delivery of unlabeled ²²⁵Ac for glioblastoma: Transport, dosimetry, and clonogenic survival modeling.
    Sabri ME et al.
  38. 31 Jul 2026· Technical innovations & patient support in radiation oncology· 6DoF head positioning· QA & dosimetry· Free full text
    Correction of image-guided radiotherapy and intrafraction motion using ExacTrac dynamic for head and neck cancer patients.
    Holst SDI et al.
  39. 31 Jul 2026· Applied radiation and isotopes· Radiopharmaceutical QC· Radiopharmacy
    Development and validation of a gamma spectrometry method for actinium-225 quantification and routine radionuclidic purity monitoring.
    Espino López R et al.
  40. 31 Jul 2026· Surgical neurology international· SRS / intracranial· Therapeutic
    Catheter-tract recurrence after Ommaya reservoir-assisted cyst decompression followed by stereotactic radiosurgery for cystic brain metastasis: A case report.
    Yamamoto Y et al.
  41. 31 Jul 2026· Ga-68 PSMA PET· Diagnostic· Free full text
    Diagnostic Accuracy of Prostate-Specific Membrane Antigen PET/CT for Pelvic Lymph Node Staging in Intermediate-to-High-Risk Prostate Cancer: A Systematic Review and Meta-Analysis
    Mehdikhani B et al.
  42. 31 Jul 2026· Journal of neurosurgery. Spine· SBRT delivery· Therapeutic
    The impact of lesion size on outcomes following stereotactic body radiotherapy for spinal metastases.
    Lilly DT et al.
  43. 31 Jul 2026· International journal of radiation oncology, biology, physics· SBRT delivery· Therapeutic
    EMPTY-RT: A Phase 2 Trial of Prostate Stereotactic Body Radiotherapy with an Empty Bladder Approach.
    Murthy V et al.
  44. 30 Jul 2026· Small (Weinheim an der Bergstrasse, Germany)· Radiopharmaceutical QC· Radiopharmacy· Free full text
    Theranostic π Electron-Stabilized Polymeric Micelles for PET Imaging-Guided Drug Delivery to Tumors.
    Wang A et al.
  45. 30 Jul 2026· ESMO open· Diagnostic
    Era-specific prognostic factors and an interpretable machine-learning survival model for renal cell carcinoma brain metastases.
    Ozgul S et al.
  46. 30 Jul 2026· Clinical and molecular hepatology· SBRT delivery· Therapeutic
    External beam radiotherapy versus local ablation therapy for the treatment of hepatocellular carcinoma: a systematic review and meta-analysis.
    Bae SH et al.
  47. 30 Jul 2026· Journal of nuclear medicine : official publication, Society of Nuclear Medicine· Lu-177 PSMA· Therapeutic
    A Phase 2, Open-Label, Randomized Controlled Trial Evaluating Safety and Efficacy of Dose-Intensified Versus Standard Dosing Regimens of [¹⁷⁷Lu]Lu-PSMA-597 in mCRPC (OPTIMAL-PSMA).
    Khan S et al.
  48. 30 Jul 2026· Journal of nuclear medicine : official publication, Society of Nuclear Medicine· Lu-177 PSMA· Therapeutic· Theranostic
    Tumor and Organ Dose Estimates from ¹⁷⁷Lu-PSMA-617 Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer: Results from the RESIST-PC Phase 2 Trial.
    Ells Z et al.
  49. 29 Jul 2026· Pharmaceuticals (Basel, Switzerland)· Radiopharmaceutical QC· Radiopharmacy· Free full text
    Sarcosine-Based Pharmacokinetic Optimization and Fluorescent Dye Library Evaluation of Dual-Labeled PSMA Inhibitors for Fluorescence-Guided Surgery.
    Minges P et al.
  50. 29 Jul 2026· Clinical oncology (Royal College of Radiologists (Great Britain))· Thermoplastic masks· QA & dosimetry
    UK Photon Radiotherapy Practice for Oligodendroglioma -Data From the Analysis of Proton vs Photon Radiotherapy in Oligodendroglioma and Assessment of Cognitive Health Trial (ISRCTN:1339049) Radiotherapy Quality Assurance (RTQA) Programme.
    Golten J et al.
  51. 29 Jul 2026· Lung cancer (Amsterdam, Netherlands)· Therapeutic
    The limits of pooled evidence in early-stage NSCLC: are we comparing treatments or patients?
    van Rossum PSN et al.
  52. 29 Jul 2026· Diagnostic· Free full text
    RSU: A Novel RectifiedSineUnit Activation Function for Robust Pathological Diagnosis Across Multi-Cancer Datasets
    Sarwar MS et al.
  53. 29 Jul 2026· International journal of radiation oncology, biology, physics· Adaptive radiotherapy· QA & dosimetry· Therapeutic
    Development and in silico validation of an online adaptive workflow for proton therapy with an in-room synchrocyclotron and CT-on-rails.
    Zhang H et al.
  54. 29 Jul 2026· International journal of radiation oncology, biology, physics· Ga-68 PSMA PET· Therapeutic
    Defining Intraprostatic Gross Tumor Volume and Micro-boosting through Consensus: A Contour-Based Modified Delphi Consensus.
    Mendez LC et al.
  55. 29 Jul 2026· The British journal of radiology· In-vivo dosimetry· QA & dosimetry
    Results of an international survey of SunCHECK Patient users: consensus and benchmark data for plan verification, pre-treatment quality assurance and in vivo dosimetry tolerances.
    Haughey A et al.
  56. 29 Jul 2026· Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)· Linac QA· QA & dosimetry
    Technical evaluation of a multipurpose phantom for selected CBCT QA endpoints across linac platforms.
    Huh Y et al.
  57. 29 Jul 2026· Cancer research· Ac-225 alpha therapy· Theranostic
    SEZ6-Targeted PET Imaging and Alpha-Particle Radioimmunotherapy is Effective for Detection and Treatment of Small Cell Lung Cancer.
    Ghaemi B et al.
  58. 29 Jul 2026· Cancer biotherapy & radiopharmaceuticals· Lu-177 PSMA· Therapeutic
    Prognostic Factor Analysis and Nomogram Development in Castration-Resistant Prostate Cancer with Visceral Metastases for Future Radionuclide Therapy Selection.
    Xu P et al.
  59. 28 Jul 2026· Clinical nuclear medicine· Lu-177 FAPI· Diagnostic
    18 F-FAPI-04 PET/CT Reveals Thoracic Duct Tumor Infiltration Secondary to Gastric Cancer.
    Chen D et al.
  60. 28 Jul 2026· Radiation protection dosimetry· Personal / occupational dosimetry· Radiation safety
    Analysis of abnormal results in personal dose monitoring of radiation workers in Beijing, China from 2021 to 2025.
    Qingxiang T et al.